Pseudobulbar Affect in Multiple Sclerosis Patients

The aim of the study was to determine the prevalence of pseudobulbar affect (PBA) in patients with multiple sclerosis (MS) and to analyze the link between PBA and patient age, sex, clinical course of MS, disease duration and degree of disability. The study was conducted on 79 MS patients that underw...

Full description

Bibliographic Details
Main Authors: Viktor Vidović, Merisanda Časar Rovazdi, Oto Kraml, Vanja Bašić Kes
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2015-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:http://hrcak.srce.hr/file/214208
id doaj-8c3053a4f44c4f3e96807cf729ae06ae
record_format Article
spelling doaj-8c3053a4f44c4f3e96807cf729ae06ae2020-11-24T23:10:20ZengSestre Milosrdnice University hospital, Institute of Clinical Medical Research Acta Clinica Croatica0353-94661333-94512015-01-0154.2.159163Pseudobulbar Affect in Multiple Sclerosis PatientsViktor Vidović0Merisanda Časar Rovazdi1Oto Kraml2Vanja Bašić Kes3Lipik Special Hospital for Medical Rehabilitation, Lipik, CroatiaLipik Special Hospital for Medical Rehabilitation, Lipik, CroatiaLipik Special Hospital for Medical Rehabilitation, Lipik, CroatiaUniversity Department of Neurology, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaThe aim of the study was to determine the prevalence of pseudobulbar affect (PBA) in patients with multiple sclerosis (MS) and to analyze the link between PBA and patient age, sex, clinical course of MS, disease duration and degree of disability. The study was conducted on 79 MS patients that underwent inpatient rehabilitation at the Lipik Special Hospital for Medical Rehabilitation in the period from August 15, 2014 to February 15, 2015. PBA is a term used for an emotional disinhibition syndrome characterized by sudden and involuntary episodes of crying or laughing which are not in proportion to the stimulus applied or occur without stimulus. The condition can be present in patients with various neurological disorders, such as amyotrophic lateral sclerosis, Alzheimer’s disease, Parkinson’s disease, patients having recovered from stroke, or following traumatic brain injury. The estimated prevalence in patients with MS ranges from 10% to 46.2%. As a measuring instrument in the study, we used the Center for Neurologic Study-Lability Scale (CNS-LS), where a sum ≥17 denoted positive finding. The total number of respondents was 79, of which 33 (41.8%) met the CNS-LS criteria for the diagnosis of PBA. There was no statistically significant correlation between PBA, age and degree of disability, although PBA was more common in women and in patients with a secondary progressive form of the disease. We found that 42.4% of respondents with positive CNS-LS criteria for PBA did not inform their neurologist on the presence of sudden mood changes. The high frequency of PBA and the fact that a significant proportion of patients did not inform the neurologist on their affective disturbances call for an active approach to diagnosis and treatment. http://hrcak.srce.hr/file/214208Multiple sclerosis – complicationsPseudobulbar affectCNS-LS
collection DOAJ
language English
format Article
sources DOAJ
author Viktor Vidović
Merisanda Časar Rovazdi
Oto Kraml
Vanja Bašić Kes
spellingShingle Viktor Vidović
Merisanda Časar Rovazdi
Oto Kraml
Vanja Bašić Kes
Pseudobulbar Affect in Multiple Sclerosis Patients
Acta Clinica Croatica
Multiple sclerosis – complications
Pseudobulbar affect
CNS-LS
author_facet Viktor Vidović
Merisanda Časar Rovazdi
Oto Kraml
Vanja Bašić Kes
author_sort Viktor Vidović
title Pseudobulbar Affect in Multiple Sclerosis Patients
title_short Pseudobulbar Affect in Multiple Sclerosis Patients
title_full Pseudobulbar Affect in Multiple Sclerosis Patients
title_fullStr Pseudobulbar Affect in Multiple Sclerosis Patients
title_full_unstemmed Pseudobulbar Affect in Multiple Sclerosis Patients
title_sort pseudobulbar affect in multiple sclerosis patients
publisher Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
series Acta Clinica Croatica
issn 0353-9466
1333-9451
publishDate 2015-01-01
description The aim of the study was to determine the prevalence of pseudobulbar affect (PBA) in patients with multiple sclerosis (MS) and to analyze the link between PBA and patient age, sex, clinical course of MS, disease duration and degree of disability. The study was conducted on 79 MS patients that underwent inpatient rehabilitation at the Lipik Special Hospital for Medical Rehabilitation in the period from August 15, 2014 to February 15, 2015. PBA is a term used for an emotional disinhibition syndrome characterized by sudden and involuntary episodes of crying or laughing which are not in proportion to the stimulus applied or occur without stimulus. The condition can be present in patients with various neurological disorders, such as amyotrophic lateral sclerosis, Alzheimer’s disease, Parkinson’s disease, patients having recovered from stroke, or following traumatic brain injury. The estimated prevalence in patients with MS ranges from 10% to 46.2%. As a measuring instrument in the study, we used the Center for Neurologic Study-Lability Scale (CNS-LS), where a sum ≥17 denoted positive finding. The total number of respondents was 79, of which 33 (41.8%) met the CNS-LS criteria for the diagnosis of PBA. There was no statistically significant correlation between PBA, age and degree of disability, although PBA was more common in women and in patients with a secondary progressive form of the disease. We found that 42.4% of respondents with positive CNS-LS criteria for PBA did not inform their neurologist on the presence of sudden mood changes. The high frequency of PBA and the fact that a significant proportion of patients did not inform the neurologist on their affective disturbances call for an active approach to diagnosis and treatment.
topic Multiple sclerosis – complications
Pseudobulbar affect
CNS-LS
url http://hrcak.srce.hr/file/214208
work_keys_str_mv AT viktorvidovic pseudobulbaraffectinmultiplesclerosispatients
AT merisandacasarrovazdi pseudobulbaraffectinmultiplesclerosispatients
AT otokraml pseudobulbaraffectinmultiplesclerosispatients
AT vanjabasickes pseudobulbaraffectinmultiplesclerosispatients
_version_ 1725607616510427136